Cargando…

Relevance of BRAF Subcellular Localization and Its Interaction with KRAS and KIT Mutations in Skin Melanoma

Although skin melanoma (SKM) represents only one-quarter of newly diagnosed skin malignant tumors, it presents a high mortality rate. Hence, new prognostic and therapeutic tools need to be developed. This study focused on investigating the prognostic value of the subcellular expression of BRAF, KRAS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beleaua, Marius-Alexandru, Jung, Ioan, Braicu, Cornelia, Milutin, Doina, Gurzu, Simona
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584522/ https://www.ncbi.nlm.nih.gov/pubmed/34769348 http://dx.doi.org/10.3390/ijms222111918

Ejemplares similares

SOX11, SOX10 and MITF Gene Interaction: A Possible Diagnostic Tool in Malignant Melanoma
por: Beleaua, Marius-Alexandru, et al.
Publicado: (2021)

Unusual Location of Hydatid Cysts: Report of Two Cases in the Heart and Hip Joint of Romanian Patients
por: Gurzu, Simona, et al.
Publicado: (2017)

Subcellular Expression of Maspin in Colorectal Cancer: Friend or Foe
por: Gurzu, Simona, et al.
Publicado: (2021)

KIT Mutation Incidence and Pattern of Melanoma in Central Europe
por: Doma, V., et al.
Publicado: (2019)

Significant Shrinkage of Multifocal Liver Metastases and Long-Term Survival in a Patient With Rectal Cancer, After Trans-Arterial Chemoembolization (TACE): A Case Report
por: Suciu, Bogdan Andrei, et al.
Publicado: (2015)

Targeted therapy in melanoma – the role of BRAF, RAS and KIT mutations
por: Goldinger, Simone M., et al.
Publicado: (2013)

Mutation analysis of BRAF and KIT in circulating melanoma cells at the single cell level
por: Sakaizawa, K, et al.
Publicado: (2012)

Prevalence of BRAF, NRAS and c-KIT Mutations in Slovenian Patients with Advanced Melanoma
por: Moltara, Maja Ebert, et al.
Publicado: (2018)

Frequency of BRAF Mutation and Clinical Relevance for Primary Melanomas
por: Lee, Hyoun Wook, et al.
Publicado: (2012)

Significant Improvement in Detecting BRAF, KRAS, and EGFR Mutations Using Next-Generation Sequencing as Compared with FDA-Cleared Kits
por: Ma, Wanlong, et al.
Publicado: (2017)

PKCθ utility in diagnosing c-KIT/DOG-1 double negative gastrointestinal stromal tumors
por: Kövecsi, Attila, et al.
Publicado: (2017)

KIT, NRAS and BRAF mutations in sinonasal mucosal melanoma: a study of 56 cases
por: Zebary, A, et al.
Publicado: (2013)

Mutations in the BRAF, NRAS, and C-KIT Genes of Patients Diagnosed with Melanoma in Colombia Population
por: Gutiérrez-Castañeda, Luz D., et al.
Publicado: (2020)

Maspin subcellular expression in wild-type and mutant TP53 gastric cancers
por: Gurzu, Simona, et al.
Publicado: (2020)

Recurrent KRAS, KIT and SF3B1 mutations in melanoma of the female genital tract
por: Cai, Yuan-jun, et al.
Publicado: (2021)

Semi-supervised prediction of protein subcellular localization using abstraction augmented Markov models
por: Caragea, Cornelia, et al.
Publicado: (2010)

Bioanalysis of MMR and KRAS – a key factor in diagnosis of colorectal cancer
por: Stefan-van Staden, Raluca-Ioana, et al.
Publicado: (2023)

KRAS and BRAF genotyping of synchronous colorectal carcinomas
por: GIANNINI, RICCARDO, et al.
Publicado: (2014)

DNA extraction from paraffin embedded colorectal carcinoma samples: A comparison study of manual vs automated methods, using four commercially kits
por: Kovacs, Zsolt, et al.
Publicado: (2019)

Frequent KIT mutations in skin lesions of patients with BRAF wild-type Langerhans cell histiocytosis
por: Tóth, Béla, et al.
Publicado: (2020)

Molecular Targeted Approaches for Advanced BRAF V600, N-RAS, c-KIT, and GNAQ Melanomas
por: Giovanni, Ponti, et al.
Publicado: (2014)

KIT, NRAS, BRAF and FMNL2 mutations in oral mucosal melanoma and a systematic review of the literature
por: Chen, Feng, et al.
Publicado: (2018)

Frequency of mutations in BRAF, NRAS, and KIT in different populations and histological subtypes of melanoma: a systemic review
por: Gutiérrez-Castañeda, Luz Dary, et al.
Publicado: (2020)

The Driverless Triple-Wild-Type (BRAF, RAS, KIT) Cutaneous Melanoma: Whole Genome Sequencing Discoveries
por: Pipek, Orsolya, et al.
Publicado: (2023)

Concomitant KIT/BRAF and PDGFRA/BRAF mutations are rare events in gastrointestinal stromal tumors
por: Rossi, Sabrina, et al.
Publicado: (2016)

Erratum to “Molecular Targeted Approaches for Advanced BRAF V600, N-RAS, c-KIT, and GNAQ Melanoma”
por: Ponti, Giovanni, et al.
Publicado: (2014)

Simultaneous identification of 36 mutations in KRAS codons 61and 146, BRAF, NRAS, and PIK3CA in a single reaction by multiplex assay kit
por: Bando, Hideaki, et al.
Publicado: (2013)

Prognostic Roles of BRAF, KIT, NRAS, IGF2R and SF3B1 Mutations in Mucosal Melanomas
por: Wróblewska, Joanna P., et al.
Publicado: (2021)

KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer
por: Sclafani, Francesco, et al.
Publicado: (2018)

The relevance of BRAF G469A mutation in determining the response to therapy in metastatic melanoma
por: Porcelli, Letizia, et al.
Publicado: (2015)

Frequent mutations of KRAS in addition to BRAF in colorectal serrated adenocarcinoma
por: Stefanius, Karoliina, et al.
Publicado: (2011)

EGFR, PIK3CA, KRAS and BRAF mutations in meningiomas
por: BUJKO, MATEUSZ, et al.
Publicado: (2014)

Mitochondrial Respiration in KRAS and BRAF Mutated Colorectal Tumors and Polyps
por: Rebane-Klemm, Egle, et al.
Publicado: (2020)

KRAS/NRAS/BRAF Mutations as Potential Targets in Multiple Myeloma
por: Pasca, Sergiu, et al.
Publicado: (2019)

Commentary
por: Gurzu, Simona, et al.
Publicado: (2014)

ROCK inhibitor enhances the growth and migration of BRAF‐mutant skin melanoma cells
por: Chang, Fei, et al.
Publicado: (2018)

Subcellular Localization Relevance and Cancer-Associated Mechanisms of Diacylglycerol Kinases
por: Fazio, Antonietta, et al.
Publicado: (2020)

Comparison of c-Kit expression between primary and metastatic melanoma of skin and mucosa
por: Sari Aslani, Fatemeh, et al.
Publicado: (2015)

Allele frequencies of BRAFV600 mutations in primary melanomas and matched metastases and their relevance for BRAF inhibitor therapy in metastatic melanoma
por: Satzger, Imke, et al.
Publicado: (2015)

A real‐world study of adjuvant anti‐PD ‐1 immunotherapy on stage III melanoma with BRAF, NRAS, and KIT mutations
por: Sun, Wei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3glcq8k3a6jegbgjc2i571mt3v